D N Fundamental Relationships

DNA -- Israel Stock  

ILS 22.60  0.80  0.03%

The Drivers Module shows relationships between D N's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of D N A Biomedical Solutions Ltd over time as well as its relative position and ranking within its peers. Additionally see Investing Opportunities.

D N A Return On Equity vs. Total Asset Fundamental Analysis

D N A Biomedical Solutions Ltd is rated below average in total asset category among related companies. It is rated below average in return on equity category among related companies .
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
D N 
Total Asset 
Tangible Assets 
Intangible Assets 
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of a company property, and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
D N 
Return on Equity 
Net Income 
Total Equity 
For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

D N A Return On Equity Comparison

D N is currently under evaluation in return on equity category among related companies.
Search macroaxis.com